[[abstract]]Post-translational modifications (PTMs), such as glycosylation and palmitoylation, are critical to protein folding, stability, intracellular trafficking, and function. Understanding regulation of PTMs of SARS-CoV-2 spike (S) protein could help the therapeutic drug design. Herein, the VSV vector was used to produce SARS-CoV-2 S pseudoviruses to examine the roles of the (611)LYQD(614) and cysteine-rich motifs in S protein maturation and virus infectivity. Our results show that (LY612)-L-611 mutation alters S protein intracellular trafficking and reduces cell surface expression level. It also changes S protein glycosylation pattern and decreases pseudovirus infectivity. The S protein contains four cysteine-rich clusters with cluste...
The severe acute respiratory syndrome coronavirus 2 spike (S) glycoprotein facilitates receptor bind...
Abstract Coronavirus disease 2019 (COVID-19), a highly infectious disease caused by severe acute res...
The dense glycan shield is an essential feature of the SARS-CoV-2 spike (S) architecture, key to imm...
[[abstract]]Post-translational modifications (PTMs), such as glycosylation and palmitoylation, are c...
AbstractThe SARS–coronavirus (SARS–CoV) is the etiological agent of the severe acute respiratory syn...
AbstractCoronaviruses are enveloped RNA viruses that generally cause mild disease in humans. However...
The structure and post-translational processing of the SARS-CoV-2 spike glycoprotein (S) is intimate...
The SARS-coronavirus (SARS-CoV) is the etiological agent of the severe acute respiratory syndrome (S...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is severely affecting the worldwide popu...
AbstractThe SARS-coronavirus (SARS-CoV) is the etiological agent of severe acute respiratory syndrom...
Viruses have evolved complex ways to penetrate host barriers and cause disease. One of the most impo...
The emergence of SARS-CoV-2 variants alters the efficacy of existing immunity, whether arisen natura...
Several SARS-CoV-2 variants emerged that harbor mutations in the surface unit of the viral spike (S)...
The emergence of SARS-CoV-2 variants alters the efficacy of existing immunity, whether arisen natura...
AbstractThe spike protein S of coronaviruses contains a highly conserved cytoplasmic cysteine-rich m...
The severe acute respiratory syndrome coronavirus 2 spike (S) glycoprotein facilitates receptor bind...
Abstract Coronavirus disease 2019 (COVID-19), a highly infectious disease caused by severe acute res...
The dense glycan shield is an essential feature of the SARS-CoV-2 spike (S) architecture, key to imm...
[[abstract]]Post-translational modifications (PTMs), such as glycosylation and palmitoylation, are c...
AbstractThe SARS–coronavirus (SARS–CoV) is the etiological agent of the severe acute respiratory syn...
AbstractCoronaviruses are enveloped RNA viruses that generally cause mild disease in humans. However...
The structure and post-translational processing of the SARS-CoV-2 spike glycoprotein (S) is intimate...
The SARS-coronavirus (SARS-CoV) is the etiological agent of the severe acute respiratory syndrome (S...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is severely affecting the worldwide popu...
AbstractThe SARS-coronavirus (SARS-CoV) is the etiological agent of severe acute respiratory syndrom...
Viruses have evolved complex ways to penetrate host barriers and cause disease. One of the most impo...
The emergence of SARS-CoV-2 variants alters the efficacy of existing immunity, whether arisen natura...
Several SARS-CoV-2 variants emerged that harbor mutations in the surface unit of the viral spike (S)...
The emergence of SARS-CoV-2 variants alters the efficacy of existing immunity, whether arisen natura...
AbstractThe spike protein S of coronaviruses contains a highly conserved cytoplasmic cysteine-rich m...
The severe acute respiratory syndrome coronavirus 2 spike (S) glycoprotein facilitates receptor bind...
Abstract Coronavirus disease 2019 (COVID-19), a highly infectious disease caused by severe acute res...
The dense glycan shield is an essential feature of the SARS-CoV-2 spike (S) architecture, key to imm...